204 related articles for article (PubMed ID: 24225993)
1. A new mutation in the C-SH2 domain of PTPN11 causes Noonan syndrome with multiple giant cell lesions.
Carapito R; Paul N; Untrau M; Ott L; Corradini N; Poignant S; Geffroy L; Caldagues E; Heymann MF; Cassagnau E; Isidor B; Bahram S
J Hum Genet; 2014 Jan; 59(1):57-9. PubMed ID: 24225993
[TBL] [Abstract][Full Text] [Related]
2. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome.
Neumann TE; Allanson J; Kavamura I; Kerr B; Neri G; Noonan J; Cordeddu V; Gibson K; Tzschach A; Krüger G; Hoeltzenbein M; Goecke TO; Kehl HG; Albrecht B; Luczak K; Sasiadek MM; Musante L; Laurie R; Peters H; Tartaglia M; Zenker M; Kalscheuer V
Eur J Hum Genet; 2009 Apr; 17(4):420-5. PubMed ID: 18854871
[TBL] [Abstract][Full Text] [Related]
3. Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation.
Bertola DR; Pereira AC; de Oliveira PS; Kim CA; Krieger JE
Am J Med Genet A; 2004 Nov; 130A(4):378-83. PubMed ID: 15384080
[TBL] [Abstract][Full Text] [Related]
4. Giant cell lesions in noonan syndrome: case report and review of the literature.
Bufalino A; Carrera M; Carlos R; Coletta RD
Head Neck Pathol; 2010 Jun; 4(2):174-7. PubMed ID: 20383758
[TBL] [Abstract][Full Text] [Related]
5. Case report: Noonan syndrome with multiple giant cell lesions and review of the literature.
Karbach J; Coerdt W; Wagner W; Bartsch O
Am J Med Genet A; 2012 Sep; 158A(9):2283-9. PubMed ID: 22848035
[TBL] [Abstract][Full Text] [Related]
6. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
[TBL] [Abstract][Full Text] [Related]
7. Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome.
Pannone L; Bocchinfuso G; Flex E; Rossi C; Baldassarre G; Lissewski C; Pantaleoni F; Consoli F; Lepri F; Magliozzi M; Anselmi M; Delle Vigne S; Sorge G; Karaer K; Cuturilo G; Sartorio A; Tinschert S; Accadia M; Digilio MC; Zampino G; De Luca A; Cavé H; Zenker M; Gelb BD; Dallapiccola B; Stella L; Ferrero GB; Martinelli S; Tartaglia M
Hum Mutat; 2017 Apr; 38(4):451-459. PubMed ID: 28074573
[TBL] [Abstract][Full Text] [Related]
8. SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions.
Beneteau C; Cavé H; Moncla A; Dorison N; Munnich A; Verloes A; Leheup B
Eur J Hum Genet; 2009 Oct; 17(10):1216-21. PubMed ID: 19352411
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
[TBL] [Abstract][Full Text] [Related]
11. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
Tartaglia M; Kalidas K; Shaw A; Song X; Musat DL; van der Burgt I; Brunner HG; Bertola DR; Crosby A; Ion A; Kucherlapati RS; Jeffery S; Patton MA; Gelb BD
Am J Hum Genet; 2002 Jun; 70(6):1555-63. PubMed ID: 11992261
[TBL] [Abstract][Full Text] [Related]
12. Genetics and variation in phenotype in Noonan syndrome.
Jongmans M; Otten B; Noordam K; van der Burgt I
Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature.
Jongmans M; Sistermans EA; Rikken A; Nillesen WM; Tamminga R; Patton M; Maier EM; Tartaglia M; Noordam K; van der Burgt I
Am J Med Genet A; 2005 Apr; 134A(2):165-70. PubMed ID: 15723289
[TBL] [Abstract][Full Text] [Related]
14. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.
Papadopoulos G; Papadopoulou A; Kosma K; Papadimitriou A; Papaevangelou V; Kanaka-Gantenbein C; Bountouvi E; Kitsiou-Tzeli S
Eur J Pediatr; 2022 Oct; 181(10):3691-3700. PubMed ID: 35904599
[TBL] [Abstract][Full Text] [Related]
16. A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.
Edwards JJ; Martinelli S; Pannone L; Lo IF; Shi L; Edelmann L; Tartaglia M; Luk HM; Gelb BD
Am J Med Genet A; 2014 Sep; 164A(9):2351-5. PubMed ID: 24891296
[TBL] [Abstract][Full Text] [Related]
17. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
Klapecki J; Obersztyn E; Laniewski-Wollk M; Szpecht-Potocka A; Mazurczak T
Med Wieku Rozwoj; 2006; 10(1 Pt 2):289-308. PubMed ID: 17028394
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlations in Noonan syndrome.
Zenker M; Buheitel G; Rauch R; Koenig R; Bosse K; Kress W; Tietze HU; Doerr HG; Hofbeck M; Singer H; Reis A; Rauch A
J Pediatr; 2004 Mar; 144(3):368-74. PubMed ID: 15001945
[TBL] [Abstract][Full Text] [Related]
19. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
20. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
